BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 11859853)

  • 21. Endothelial haemostatic factors may be associated with mortality in patients on long-term anticoagulant treatment.
    Brännström M; Jansson JH; Boman K; Nilsson TK
    Thromb Haemost; 1995 Aug; 74(2):612-5. PubMed ID: 8584993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive-behavioural stress management does not improve biological cardiovascular risk indicators in women with ischaemic heart disease: a randomized-controlled trial.
    Claesson M; Birgander LS; Jansson JH; Lindahl B; Burell G; Asplund K; Mattsson C
    J Intern Med; 2006 Oct; 260(4):320-31. PubMed ID: 16961669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concentrations of plasminogen activators and their inhibitors in blood preconceptionally, during and after pregnancy.
    Coolman M; de Groot CJ; Steegers EA; Geurts-Moespot A; Thomas CM; Steegers-Theunissen RP; Sweep FC
    Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):22-8. PubMed ID: 16584829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of the fibrinolytic system and utilization of the coagulation inhibitors in sepsis: comparison with severe sepsis and septic shock.
    Mavrommatis AC; Theodoridis T; Economou M; Kotanidou A; El Ali M; Christopoulou-Kokkinou V; Zakynthinos SG
    Intensive Care Med; 2001 Dec; 27(12):1853-9. PubMed ID: 11797019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute release of plasminogen activator inhibitor-1 in ST-segment elevation myocardial infarction predicts mortality.
    Collet JP; Montalescot G; Vicaut E; Ankri A; Walylo F; Lesty C; Choussat R; Beygui F; Borentain M; Vignolles N; Thomas D
    Circulation; 2003 Jul; 108(4):391-4. PubMed ID: 12860898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evaluation of the fibrinolytic system in myocardial infarction].
    Moreno JA; Cornudella R; Gálvez M; Angós JA; Romero S; Gutiérrez M
    Sangre (Barc); 1994 Feb; 39(1):23-7. PubMed ID: 8197514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of sex steroids on plasma levels of marker proteins of endothelial cell functioning.
    van Kesteren PJ; Kooistra T; Lansink M; van Kamp GJ; Asscheman H; Gooren LJ; Emeis JJ; Vischer UM; Stehouwer CD
    Thromb Haemost; 1998 May; 79(5):1029-33. PubMed ID: 9609242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Imbalance of plasminogen activator inhibitor-I/ tissue plasminogen activator and tissue factor/tissue factor pathway inhibitor in young Japanese men with myocardial infarction.
    Saigo M; Abe S; Ogawa M; Yamashita T; Biro S; Minagoe S; Maruyama I; Tei C
    Thromb Haemost; 2001 Nov; 86(5):1197-203. PubMed ID: 11816707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of imidapril therapy on endogenous fibrinolysis in patients with recent myocardial infarction.
    Soejima H; Ogawa H; Yasue H; Suefuji H; Kaikita K; Nishiyama K
    Clin Cardiol; 1997 May; 20(5):441-5. PubMed ID: 9134274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive value of fibrinolytic factors in coronary heart disease.
    Wiman B
    Scand J Clin Lab Invest Suppl; 1999; 230():23-31. PubMed ID: 10389198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor.
    Thögersen AM; Jansson JH; Boman K; Nilsson TK; Weinehall L; Huhtasaari F; Hallmans G
    Circulation; 1998 Nov; 98(21):2241-7. PubMed ID: 9826309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibrinolytic dysfunction in insulin-resistant women with previous gestational diabetes.
    Farhan S; Winzer C; Tura A; Quehenberger P; Bieglmaier C; Wagner OF; Huber K; Waldhäusl W; Pacini G; Kautzky-Willer A
    Eur J Clin Invest; 2006 May; 36(5):345-52. PubMed ID: 16634839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of long-term erythropoietin therapy on fibrinolytic system in haemodialyzed patients.
    Pawlak K; Pawlak D; Mysliwiec M
    Thromb Res; 2008; 121(6):787-91. PubMed ID: 17869326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of octreotide on epidermal growth factor receptor, tissue plasminogen activator, and plasminogen activator inhibitor during intraperitoneal adhesion formation.
    Lai HS; Chen Y; Chang KJ; Chen WJ
    J Gastroenterol; 2003; 38(6):555-60. PubMed ID: 12825131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bradykinin stimulates the release of tissue plasminogen activator in human coronary circulation: effects of angiotensin-converting enzyme inhibitors.
    Minai K; Matsumoto T; Horie H; Ohira N; Takashima H; Yokohama H; Kinoshita M
    J Am Coll Cardiol; 2001 May; 37(6):1565-70. PubMed ID: 11345366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low level of tissue plasminogen activator activity in non-diabetic patients with a first myocardial infarction.
    Lundblad D; Dinesen B; Rautio A; Røder ME; Eliasson M
    J Intern Med; 2005 Jul; 258(1):13-20. PubMed ID: 15953128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eprosartan effect on fibrinolytic/hemostatic variables in arterial hypertension: a comparative study to losartan.
    Makris TK; Stavroulakis G; Papadopoulos DP; Krespi P; Hatzizacharias A; Zilidis A; Tsoukala C; Votteas VE
    Drugs Exp Clin Res; 2004; 30(3):125-32. PubMed ID: 15366789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Highly stable plasminogen activator inhibitor type one (VLHL PAI-1) protects fibrin clots from tissue plasminogen activator-mediated fibrinolysis.
    Jankun J; Aleem AM; Selman SH; Skrzypczak-Jankun E; Lysiak-Szydlowska W; Grafos N; Fryer HJ; Greenfield RS
    Int J Mol Med; 2007 Nov; 20(5):683-7. PubMed ID: 17912461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of three doses of enalapril in preventing left ventricular remodeling after acute myocardial infarction in the rat.
    Yang Y; Zhang P; Song L; Ruan Y; Xu X; Li Y; Zhou Y; Tian Y; Xu Y; Chen Z
    Chin Med J (Engl); 2002 Mar; 115(3):347-51. PubMed ID: 11940361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential effects of enalapril and nitrendipine on the fibrinolytic system in essential hypertension.
    Sakata K; Shirotani M; Yoshida H; Urano T; Takada Y; Takada A
    Am Heart J; 1999 Jun; 137(6):1094-9. PubMed ID: 10347337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.